Biocompatible in situ gelling hydrogel formulations for intra-articular drug delivery
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3. Synthesis of DIBAC

6. 1H-NMR characterization of DIBAC

• Osteoarthritis (OA) is a progressive disease impacting > 4
million Canadian adults [1]. OA results in the overall
degeneration of the joint which is typically accompanied
by pain and stiffness that can be debilitating [2].

5-[11,12-Didehydrodibenzo[b,f]azocin-5(6H)-yl]-4-oxobutanoic Acid (DIBAC)

• Currently there are no disease-modifying treatments
available that aim to slow the progression of OA [2].
• An injectable hydrogel formulation developed in our lab
using a free radical crosslinking system has shown
promise for the sustained release of disease-modifying
drugs in the joints.
• Alternative crosslinking mechanisms are needed, that
avoid free radicals to achieve a clinically-translatable
formulation.

4. Synthesis of 4-arm PEG-DIBAC

• This study focuses on a crosslinking system that uses
copper-free click chemistry [3]. The reaction is based on
the strain-promoted azide-alkyne cycloaddition (SPAAC)
of an azido-endcapped poly(caprolactone-co-lactide)poly(ethylene glycol)-poly(caprolactone-co-lactide) (N3PCLA-PEG-PCLA-N3) triblock copolymer and a PEG star
polymer with a strained-alkyne end group, such as an
azadibenzocyclooctyne (DIBAC) [3,4].

2. Purpose

This biocompatible drug delivery system will be applied to
disease-modifying drugs to treat OA. The drug-loaded
hydrogel will be injected directly into the targeted joint as a
liquid at or below 21oC . The thermoresponsive hydrogel
will gel spontaneously at 37oC under physiological
conditions. The system will achieve a sustained drug
release over a prolonged period.

7. Conclusions and current work
•
•
•

Precursors for hydrogel formation were successfully prepared
Gelation tests are currently being carried out
The hydrogels will be further characterized through mechanical
tests including syneresis and degradation studies, in vitro
release studies, and cytotoxicity tests.

5. Synthesis of azido-endcapped PCLA-PEG-PCLA
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